Mark C. Griffiths has been named chief executive officer of Carbogen Amcis AG, a pharmaceutical process development and API manufacturer. Mr. Griffiths will have responsibility for Carbogen Amcis’ Swiss business and will report to Jay Vyas, managing director of parent company Dishman Pharmaceuticals and Chemicals Ltd.   Mr. Griffiths has worked at Carbogen Amcis for almost 10 years. Most recently, he has been working for the Dishman Group as operations advisor overseeing the design and construct...